Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biotech M&A deals dominate key Q1 metric
Fierce Biotech
Monday, April 1, 2013 - 11:22am
tags:
M&A, biotech
FDA saw early reports of severe Omontys reactions: WSJ
Fierce Pharma
Monday, April 1, 2013 - 11:20am
tags:
FDA, Omontys, Affymax, anemia, Takeda
Where Is Exelixis In The Cancer Therapeutics Market?
Seeking Alpha
Monday, April 1, 2013 - 11:01am
tags:
Exelixis, cabozantinib, Cometriq, cancer
BioMarin submits CTA for BMN-190 for Batten disease
Yahoo/Fly on the Wall
Monday, April 1, 2013 - 10:59am
tags:
Biomarin, BMN-190, Batten disease
Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Yahoo
Monday, April 1, 2013 - 10:58am
tags:
ARQ092, Daiichi Sankyo, Arqule, akt protein inhibitor, cancer
BioCryst's shares spike on hope that flu drug can rise from the grave
Fierce Biotech
Monday, April 1, 2013 - 10:55am
tags:
Biocryst, Flu, influenza, peramivir
Medivation, Astellas Pharma provide update on Phase 3 PREVAIL
Yahoo/Fly on the Wall
Monday, April 1, 2013 - 10:49am
tags:
Astellas, Medivation, metastatic castration-resistant prostate cancer, prostate cancer, Xtandi
Is There Any Potential Left In ACADIA Pharmaceuticals?
Seeking Alpha
Monday, April 1, 2013 - 10:47am
tags:
Acadia, Parkinson's Disease, pimavanserin
Understanding Why Cancer Vaccines Fail
Motley Fool
Monday, April 1, 2013 - 10:46am
tags:
cancer, vaccines, Dendreon, Provenge, Bristol-Myers Squibb, Yervoy, Sanofi, TheraCys
Endo Health's New CEO To Reveal Strategy: Good News For Investors?
Seeking Alpha
Monday, April 1, 2013 - 10:44am
tags:
Endo Health Solutions, Pharma CEOs
Another Day, Another Problem For Hospira
Pharmalot
Monday, April 1, 2013 - 10:43am
tags:
Hospira, manufacturing, recalls
Will This Court Decision Be a Thorn in the Side of Novartis?
Wall St. Cheat Sheet
Monday, April 1, 2013 - 10:39am
tags:
Novartis, India, Gleevac, patents, Glivec
Four Factors Driving Amgen's Stock Price To $102
Seeking Alpha
Monday, April 1, 2013 - 10:38am
tags:
Amgen, AbbVie, Bristol-Myers Squibb, JNJ, Merck, Eli Lilly, Pfizer
Novartis loses landmark India patent case on Glivec
Reuters
Monday, April 1, 2013 - 10:32am
tags:
patents, Novartis, India, Gleevec, Glivec
Diabetes Drug Could Rake Hundreds of Millions for J&J
Wall St. Cheat Sheet
Monday, April 1, 2013 - 10:31am
tags:
JNJ, Invokana, diabetes
AP Pharma And Ziopharm: The Differences Between Bad News
Seeking Alpha
Monday, April 1, 2013 - 10:30am
tags:
Ziopharm, AP Pharma, APF530, chemotherapy-induced nausea and vomiting
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, March 30, 2013 - 11:04am
tags:
Corcept Therapeutics, Vivus, Cempra
Pfizer May Have To Rethink Xalkori Cost Structure
Seeking Alpha
Saturday, March 30, 2013 - 11:02am
tags:
Pfizer, Xalkori, lung cancer
FDA OKs first-of-a-kind diabetes drug from J&J
Yahoo/AP
Saturday, March 30, 2013 - 11:01am
tags:
JNJ, diabetes, Invokana, type 2 diabetes
This Pharma's Dividend Is Safe for Now
Motley Fool
Saturday, March 30, 2013 - 10:57am
tags:
Eli Lilly

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.